Role of Matrix Metalloproteases in Degradation of ECM
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Vascular Spasm
Peripheral Artery Disease I: Introduction
Clot Retraction and Fibrinolysis
The Proteasome
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 19, 2026

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
Megan A Slack1, Scott M Gordon1
1From the Saha Cardiovascular Research Center and Department of Physiology, University of Kentucky College of Medicine, Lexington.
No abstract available in PubMed .